272 results
Page 2 of 14
6-K
EX-99.2
lyrmphe
22 Nov 23
Current report (foreign)
7:20pm
6-K
EX-99.1
c7sw uuuvx2bj3l
22 Nov 23
Current report (foreign)
7:20pm
6-K
EX-99.1
rzcqrncq
31 Oct 23
Current report (foreign)
6:41pm
6-K
EX-99.2
hz1t6g94d547axrfks9
30 Oct 23
Current report (foreign)
7:43am
6-K
EX-99.1
3aoo3kwapu5uvhr
25 Sep 23
Current report (foreign)
9:59pm
6-K
EX-99.1
z7gx9 tzz3dyvt
25 Sep 23
Current report (foreign)
8:10am
6-K
EX-99.2
4pw3t8w 5kok6y
31 Aug 23
Current report (foreign)
8:05am
6-K
EX-99.1
3e7qb5xrdghd7rf
31 Aug 23
Current report (foreign)
8:05am
6-K
EX-99.1
06a5rp5gip8kbv43laim
3 Aug 23
Current report (foreign)
8:56pm
6-K
EX-99.1
c1v819m904grnrmhxta4
31 Jul 23
Current report (foreign)
8:10pm
6-K
EX-99.1
hcb14amd9nqm
31 Jul 23
Current report (foreign)
8:47am
6-K
EX-99.1
tu4hjtzmp
6 Jun 23
Mesoblast Director Philip R. Krause, M.D., Appointed to Strategic Advisory Role
8:45am
424B3
todd95hk8xbyqbil1wg
26 May 23
Prospectus supplement
4:36pm
6-K
EX-99.2
l4qkcb5fk41o ilauzm
26 May 23
Current report (foreign)
7:56am
6-K
EX-99.1
15ane376llfskplwzlma
26 May 23
Current report (foreign)
7:56am
6-K
cgyqdurtvr98dvjjcfv
25 May 23
Current report (foreign)
9:33pm
F-3
goj3dk sl
18 May 23
Shelf registration (foreign)
6:06am
6-K
EX-99.1
8bqo9h0 qj
3 May 23
Appendix 4C Quarterly Activity Report
8:21am
6-K
EX-99.1
v5ctvw59j cc0owf1ga
26 Apr 23
Mesoblast Completes Private Placement
9:31pm